Lista de obras -

23rd International Symposium on Infections in the Critically Ill Patient

artículo científico publicado en 2018

A week seems to be weak: tailoring duration of antibiotic treatment in Gram-negative ventilator-associated pneumonia

artículo científico publicado en 2013

Advances in antibiotic therapy in the critically ill

artículo científico publicado en 2016

An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistance

artículo científico publicado en 2015

An international perspective on hospitalized patients with viral community-acquired pneumonia

Are preoperative oral care bundles needed to prevent postoperative pneumonia?

artículo científico publicado en 2013

Association of Country Income Level With the Characteristics and Outcomes of Critically Ill Patients Hospitalized With Acute Kidney Injury and COVID-19

artículo científico publicado en 2023

Biomarker kinetics in the prediction of VAP diagnosis: results from the BioVAP study

artículo científico publicado en 2016

Biomarkers in community-acquired pneumonia: can we do better by using them correctly?

artículo científico publicado en 2019

Biomarkers kinetics in the assessment of ventilator-associated pneumonia response to antibiotics - results from the BioVAP study.

artículo científico publicado en 2017

Burden of pneumococcal community-acquired pneumonia in adults across Europe: A literature review

artículo científico publicado en 2018

COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study

artículo científico publicado en 2021

Clinical Management of Community Acquired Pneumonia in the Elderly Patient.

artículo científico publicado en 2016

Community-acquired pneumonia in adults: Highlighting missed opportunities for vaccination

artículo científico publicado en 2016

Comparison of two prognostic scores (BSI and FACED) in a Spanish cohort of adult patients with bronchiectasis and improvement of the FACED predictive capacity for exacerbations.

artículo científico publicado en 2017

Compliance with guidelines-recommended processes in pneumonia: impact of health status and initial signs

artículo científico publicado en 2012

Concept for a study design in patients with severe community-acquired pneumonia: A randomised controlled trial with a novel IGM-enriched immunoglobulin preparation - The CIGMA study

artículo científico publicado en 2015

Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study

artículo científico publicado en 2018

Current gaps in sepsis immunology: new opportunities for translational research

scientific article published on 17 October 2019

Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data.

artículo científico publicado en 2014

Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study).

artículo científico publicado en 2018

Elaboration of Consensus Clinical Endpoints to Evaluate Antimicrobial Treatment Efficacy in Future Hospital-acquired/Ventilator-associated Bacterial Pneumonia Clinical Trials

artículo científico publicado en 2019

Endothelial adhesion molecules and multiple organ failure in patients with severe sepsis.

artículo científico publicado en 2016

Etiology of Non-Cystic Fibrosis Bronchiectasis in Adults and Its Correlation to Disease Severity

artículo científico publicado en 2015

Hospital-Acquired Pneumonia. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) Guidelines. 2019 Update

artículo científico publicado en 2020

IgM levels in plasma predict outcome in severe pandemic influenza.

artículo científico publicado en 2013

Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: an individual participant data meta-analysis.

artículo científico publicado en 2015

Importance of a registered and structured protocol when conducting systematic reviews: comments about nebulized antibiotics for ventilator-associated pneumonia

artículo científico publicado en 2015

Increased incidence of co-infection in critically ill patients with influenza

artículo científico publicado en 2016

Influenza management with new therapies

artículo científico publicado en 2020

Intensive care unit patients with lower respiratory tract nosocomial infections: the ENIRRIs project.

artículo científico publicado en 2017

International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the Eur

artículo científico publicado en 2017

Invasive Pulmonary Aspergillosis in Ventilator-Associated Pneumonia: The Hidden Enemy?

artículo científico publicado en 2020

Microbial Etiology of Pneumonia: Epidemiology, Diagnosis and Resistance Patterns

artículo científico publicado en 2016

Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial.

artículo científico publicado en 2008

Murepavadin: a new antibiotic class in the pipeline

artículo científico publicado en 2018

Neces-SARI-ly?

artículo científico publicado en 2016

New guidelines for hospital-acquired pneumonia/ventilator-associated pneumonia: USA vs. Europe

scholarly article published October 2018

New guidelines for severe community-acquired pneumonia

scientific article published on 05 January 2021

Pandemic and post-pandemic influenza A (H1N1) infection in critically ill patients

artículo científico publicado en 2011

Phenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis

artículo científico publicado en 2014

Piperacillin population pharmacokinetics in critically ill patients with multiple organ dysfunction syndrome receiving continuous venovenous haemodiafiltration: effect of type of dialysis membrane on dosing requirements.

artículo científico publicado en 2016

Predictive Performance of Risk Factors for MDR Pathogens in Nosocomial Pneumonia

artículo científico publicado en 2020

Predictors of treatment failure and clinical stability in patients with community acquired pneumonia.

artículo científico publicado en 2017

Pulmonary infections complicating ARDS

artículo científico publicado en 2020

Respiratory research networks in Europe and beyond: aims, achievements and aspirations for the 21st century.

artículo científico publicado en 2017

Risk factors for community-acquired pneumonia in adults in Europe: a literature review

artículo científico publicado en 2013

Severe community-acquired pneumonia: Characteristics and prognostic factors in ventilated and non-ventilated patients

artículo científico publicado en 2018

Soluble urokinase plasminogen activator receptor for the prediction of ventilator-associated pneumonia

artículo científico publicado en 2019

Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia.

artículo científico publicado en 2018

Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens ⬇️

artículo científico publicado el 1 de enero de 2011

The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity

scholarly article by Marcin F Osuchowski published in 2021

The EMBARC European Bronchiectasis Registry: protocol for an international observational study

artículo científico publicado en 2016

The dynamics of the pulmonary microbiome during mechanical ventilation in the intensive care unit and the association with occurrence of pneumonia.

artículo científico publicado en 2017

The effects of direct hemoperfusion using a polymyxin B-immobilized column in a pig model of severe Pseudomonas aeruginosa pneumonia

artículo científico publicado en 2016

The research agenda in VAP/HAP: next steps

artículo científico publicado en 2017

The value of open-source clinical science in pandemic response: lessons from ISARIC

artículo científico publicado en 2021

Time to blood culture positivity as a predictor of clinical outcomes and severity in adults with bacteremic pneumococcal pneumonia.

artículo científico publicado en 2017

Treatment with macrolides and glucocorticosteroids in severe community-acquired pneumonia: A post-hoc exploratory analysis of a randomized controlled trial.

artículo científico publicado en 2017

Tumor necrosis factor receptor 1 (TNFRI) for ventilator-associated pneumonia diagnosis by cytokine multiplex analysis

artículo científico publicado en 2015

Twenty-year trend in mortality among hospitalized patients with pneumococcal community-acquired pneumonia

scientific article published on 18 July 2018

Ventilator-Associated Pneumonia and PaO2/FIO2 Diagnostic Accuracy: Changing the Paradigm?

scientific article published on 14 August 2019

Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease

artículo científico publicado en 2015

Year in review in Intensive Care Medicine 2013: I. Acute kidney injury, ultrasound, hemodynamics, cardiac arrest, transfusion, neurocritical care, and nutrition.

artículo científico

Lista de obras de

23rd International Symposium on Infections in the Critically Ill Patient

A week seems to be weak: tailoring duration of antibiotic treatment in Gram-negative ventilator-associated pneumonia

Advances in antibiotic therapy in the critically ill

An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistance

An international perspective on hospitalized patients with viral community-acquired pneumonia

Are preoperative oral care bundles needed to prevent postoperative pneumonia?

Association of Country Income Level With the Characteristics and Outcomes of Critically Ill Patients Hospitalized With Acute Kidney Injury and COVID-19

Biomarker kinetics in the prediction of VAP diagnosis: results from the BioVAP study

Biomarkers in community-acquired pneumonia: can we do better by using them correctly?

Biomarkers kinetics in the assessment of ventilator-associated pneumonia response to antibiotics - results from the BioVAP study.

Burden of pneumococcal community-acquired pneumonia in adults across Europe: A literature review

COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study

Clinical Management of Community Acquired Pneumonia in the Elderly Patient.

Community-acquired pneumonia in adults: Highlighting missed opportunities for vaccination

Comparison of two prognostic scores (BSI and FACED) in a Spanish cohort of adult patients with bronchiectasis and improvement of the FACED predictive capacity for exacerbations.

Compliance with guidelines-recommended processes in pneumonia: impact of health status and initial signs

Concept for a study design in patients with severe community-acquired pneumonia: A randomised controlled trial with a novel IGM-enriched immunoglobulin preparation - The CIGMA study

Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study

Current gaps in sepsis immunology: new opportunities for translational research

Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data.

Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study).

Elaboration of Consensus Clinical Endpoints to Evaluate Antimicrobial Treatment Efficacy in Future Hospital-acquired/Ventilator-associated Bacterial Pneumonia Clinical Trials

Endothelial adhesion molecules and multiple organ failure in patients with severe sepsis.

Etiology of Non-Cystic Fibrosis Bronchiectasis in Adults and Its Correlation to Disease Severity

Hospital-Acquired Pneumonia. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) Guidelines. 2019 Update

IgM levels in plasma predict outcome in severe pandemic influenza.

Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: an individual participant data meta-analysis.

Importance of a registered and structured protocol when conducting systematic reviews: comments about nebulized antibiotics for ventilator-associated pneumonia

Increased incidence of co-infection in critically ill patients with influenza

Influenza management with new therapies

Intensive care unit patients with lower respiratory tract nosocomial infections: the ENIRRIs project.

International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the Eur

Invasive Pulmonary Aspergillosis in Ventilator-Associated Pneumonia: The Hidden Enemy?

Microbial Etiology of Pneumonia: Epidemiology, Diagnosis and Resistance Patterns

Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial.

Murepavadin: a new antibiotic class in the pipeline

Neces-SARI-ly?

New guidelines for hospital-acquired pneumonia/ventilator-associated pneumonia: USA vs. Europe

New guidelines for severe community-acquired pneumonia

Pandemic and post-pandemic influenza A (H1N1) infection in critically ill patients

Phenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis

Piperacillin population pharmacokinetics in critically ill patients with multiple organ dysfunction syndrome receiving continuous venovenous haemodiafiltration: effect of type of dialysis membrane on dosing requirements.

Predictive Performance of Risk Factors for MDR Pathogens in Nosocomial Pneumonia

Predictors of treatment failure and clinical stability in patients with community acquired pneumonia.

Pulmonary infections complicating ARDS

Respiratory research networks in Europe and beyond: aims, achievements and aspirations for the 21st century.

Risk factors for community-acquired pneumonia in adults in Europe: a literature review

Severe community-acquired pneumonia: Characteristics and prognostic factors in ventilated and non-ventilated patients

Soluble urokinase plasminogen activator receptor for the prediction of ventilator-associated pneumonia

Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia.

Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens ⬇️

The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity

The EMBARC European Bronchiectasis Registry: protocol for an international observational study

The dynamics of the pulmonary microbiome during mechanical ventilation in the intensive care unit and the association with occurrence of pneumonia.

The effects of direct hemoperfusion using a polymyxin B-immobilized column in a pig model of severe Pseudomonas aeruginosa pneumonia

The research agenda in VAP/HAP: next steps

The value of open-source clinical science in pandemic response: lessons from ISARIC

Time to blood culture positivity as a predictor of clinical outcomes and severity in adults with bacteremic pneumococcal pneumonia.

Treatment with macrolides and glucocorticosteroids in severe community-acquired pneumonia: A post-hoc exploratory analysis of a randomized controlled trial.

Tumor necrosis factor receptor 1 (TNFRI) for ventilator-associated pneumonia diagnosis by cytokine multiplex analysis

Twenty-year trend in mortality among hospitalized patients with pneumococcal community-acquired pneumonia

Ventilator-Associated Pneumonia and PaO2/FIO2 Diagnostic Accuracy: Changing the Paradigm?

Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease

Year in review in Intensive Care Medicine 2013: I. Acute kidney injury, ultrasound, hemodynamics, cardiac arrest, transfusion, neurocritical care, and nutrition.